restor3d adds patient-specific femoral implants following acquisition of Conformis
January 17, 2024
restor3d, Inc., a provider of patient-specific musculoskeletal implants based in Durham, North Carolina, USA, finalised its previously announced acquisition of Conformis, Inc., based in Billerica, Massachusetts, in September 2023. With the merger now complete, the company is expanding its delivery of clinically differentiated and cost-effective solutions for the orthopaedic sector.
restor3d utilises metal Additive Manufacturing to produce its bespoke orthopaedics. The acquisition of Conformis has added a number of exclusive patents and pending patent applications that cover personalised implants and patient-specific instrumentation for all major joints.
“We are thrilled to announce the successful achievement of one of our key initiatives post-acquisition,” stated Kurt Jacobus, Chief Executive Officer of restor3d. “Patient-specific femoral implants, which have traditionally been cast at low margin, are now 3D printed at a fraction of the cost at our facility in Durham, NC.”
This previously cleared Additive Manufacturing method for femoral implants has now been successfully commercialised, and is reported to outperform the mechanical properties of cast alternatives.
“Total knee replacement is entering an era of personalisation,” shared Dr Moby Parsons, MD, a Board-Certified orthopaedic surgeon at Portsmouth Regional Hospital. “Nowhere is this more important than implant design and I believe this is a critical element of achieving the better outcomes that today’s patients expect. restor3d’s printed patient-specific femurs take personalisation to the next level of innovation in knee replacement using form and fit to help achieve a more normal feeling. I owe it to my patients to provide the best outcome possible in every case, and this technology is a key solution to that goal.”
Download Metal AM magazine
